Flaviana Amarante

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

Journal: JAMA cardiology
Published: March 28, 2026

HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial.

HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial.

Journal: JACC. Heart failure
Published: March 11, 2026

Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.

Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction.

Journal: European journal of heart failure
Published: February 18, 2026

A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF.

A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 04, 2025

Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes.

Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes.

Journal: JACC. Heart failure
Published: October 22, 2025

Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.

Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.

Journal: Journal of the American College of Cardiology
Published: October 15, 2025

Finerenone in patients with severe heart failure: The FINEARTS-HF trial.

Finerenone in patients with severe heart failure: The FINEARTS-HF trial.

Journal: European journal of heart failure
Published: August 25, 2025

Efficacy and Safety of the Kidney Function-Based Finerenone Dosing Strategy Used in FINEARTS-HF.

Efficacy and Safety of the Kidney Function-Based Finerenone Dosing Strategy Used in FINEARTS-HF.

Journal: JACC. Heart failure
Published: August 13, 2025

Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Journal: JACC. Heart failure
Published: July 30, 2025

Finerenone in Heart Failure With Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.

Finerenone in Heart Failure With Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.

Journal: JAMA cardiology
Published: May 21, 2025

Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF Trial.

Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF Trial.

Journal: JACC. Heart failure
Published: May 05, 2025

Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial.

Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial.

Journal: Journal of the American College of Cardiology
Published: May 05, 2025
Showing 1-12 of 23

Last Updated: 09/26/2026